lncRNA SNHG16 Exerts Oncogenic Functions in Promoting Proliferation of Glioma Through Suppressing p21
- 20 Downloads
Glioma is a malignant brain tumor that accounts for 30% of all brain tumors and 80% of malignant brain tumors. This poor clinical outcome makes the study of molecular mechanisms in glioma as an urgent subject. However, the certain mechanism remains unclear. Long non-coding RNAs (lncRNAs) plays a key role in glioma development and progression. In the present study, we aimed to explore the potential mechanisms of lncRNA SNHG16 in glioma. The levels of lncRNA SNHG16 were qualified in both glioma tissues and cell lines using qRT-PCR assay. The ability of cell proliferation was tested via CCK-8 and colony formation assays. Transfections were performed to knockdown SNHG16 and its target gene p21. The cell cycles and cell apoptosis were evaluated using flow cytometry, and the expression of SNHG16, p21 and apoptosis biomarkers were qualified with qRT-PCR and western blot assays. The expression of SNHG16 were up-regulated in both glioma tissues and cell lines. Knockdown of SNHG16 was associated with poor proliferation, decreased monoclonal formation rates, but increased apoptosis rates, which also caused the high expression of p21. Moreover, p21 could mediate cell proliferation and monoclonal formation, promote cell apoptosis in glioma, which was negatively correlated with lncRNA SNHG16. The molecule mechanism experiments revealed that SNHG16 could not only inhibit the expression of p21 but also suppressed the level of caspase 3 and 9, while promoted cyclinD1 and cyclinB1 expression. lncRNA SNHG16 could promote the cell proliferation and inhibit the apoptosis of glioma through suppressing p21, indicating that lncRNA SNHG16 might be quite vital for the diagnosis and progression of glioma and could even be a novel therapeutic target for glioma.
KeywordsLong non-coding RNA SNHG16 p21 Glioma
We would like to give our sincere gratitude to the reviewers for their constructive comments.
Compliance with Ethical Standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Conflict of Interest
The authors declares that they have no conflict of interest.
- 5.Liu G et al (2018) Survival analysis for high-grade glioma patients who received comprehensive treatment. Zhong Nan Da Xue Xue Bao Yi Xue Ban 43(4):388–393Google Scholar
- 6.Li Y et al (2015) Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer. Oncotarget 6(28):25003–25016Google Scholar
- 13.Yang BY et al (2018) Long non-coding RNA SNHG16 contributes to glioma malignancy by competitively binding miR-20a-5p with E2F1. J Biol Regul Homeost Agents 32(2):251–261Google Scholar
- 19.Sun J et al (2018) RUNX3 inhibits glioma survival and invasion via suppression of the betacatenin/TCF-4 signaling pathway. J Neuro-Oncol 140(1):15–26Google Scholar
- 22.Goldbrunner R et al (2018) The treatment of gliomas in adulthood. Dtsch Arztebl Int 115(20–21):356–364Google Scholar
- 23.Hart MG et al (2013) Temozolomide for high grade glioma. Cochrane Database Syst Rev 4(4):CD007415Google Scholar
- 25.Han X et al (2018) LncRNA TUG1 affects cell viability by regulating glycolysis in osteosarcoma cells. Gene 674:87–92Google Scholar
- 27.Almnaseer ZA, Mourtada-Maarabouni M (2018) Long noncoding RNA MIAT regulates apoptosis and the apoptotic response to chemotherapeutic agents in breast cancer cell lines. Biosci Rep 38(4):BSR20180704Google Scholar
- 30.Liu Y et al (2015) Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 8(9):11480–11484Google Scholar
- 32.Wei N, Wei H, Zhang H (2018) Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577. Eur Rev Med Pharmacol Sci 22(10):3085–3093Google Scholar